Bristol Myers Squibb to Use Chai Discovery AI Models
Chai Discovery announces BMS will deploy its Chai-3 models for new therapeutics.
Joshua Meier, founder of Chai Discovery, posted that Bristol Myers Squibb will use the company's Chai-3 AI models to support discovery of new therapeutics. The announcement notes that Chai-3 has been rolled out to partners since the start of the year. Prior partners listed include Eli Lilly, Novartis, Pfizer, and argenx. Investor Sarah Guo replied that the team is sweeping large pharma and that the companies are seeing impact from the models.
Frontier drug discovery programs require frontier capabilities. Today, we’re excited to share that BMS will be using Chai’s models to support the discovery of new therapeutics. Since rolling out Chai-3 to partners at the start of this year, we’ve partnered with @EliLillyandCo,…
Reactions from ranked influencers
3 poststeam chai is doing a full sweep of large pharma — really excited that all these companies are seeing impact from the models
Frontier drug discovery programs require frontier capabilities. Today, we’re excited to share that BMS will be using Chai’s models to support the discovery of new therapeutics. Since rolling out Chai-3 to partners at the start of this year, we’ve partnered with @EliLillyandCo,…
These guys are on a tear! They are continuously bringing AI to big pharma...this has such a massive lever on society to bring life-saving and life-improving drugs to market, at scale, faster
Frontier drug discovery programs require frontier capabilities. Today, we’re excited to share that BMS will be using Chai’s models to support the discovery of new therapeutics. Since rolling out Chai-3 to partners at the start of this year, we’ve partnered with @EliLillyandCo,…
team chai is doing a full sweep of large pharma — really excited that all these companies are seeing impact from the models
Frontier drug discovery programs require frontier capabilities. Today, we’re excited to share that BMS will be using Chai’s models to support the discovery of new therapeutics. Since rolling out Chai-3 to partners at the start of this year, we’ve partnered with @EliLillyandCo,…